MARC details
000 -LEADER |
fixed length control field |
02366cam a22002658a 4500 |
001 - CONTROL NUMBER |
control field |
0000064504 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
0001 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
140609s2013 enk b 001 0 eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780470976364 (paper) |
|
International Standard Book Number |
9780470976357 (cloth) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(DNLM)101587464 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DNLM/DLC |
Transcribing agency |
DLC |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1 9 |
Edition number |
23 |
084 ## - OTHER CLASSIFICATION NUMBER |
Classification number |
615.19 |
Item number |
GAI-E |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Gaisford, Simon. |
245 10 - TITLE STATEMENT |
Title |
Essentials of pharmaceutical preformulation |
Medium |
[Book] / |
Statement of responsibility, etc. |
Simon Gaisford and Mark Saunders. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Chichester, West Sussex : |
Name of publisher, distributor, etc. |
John Wiley & Sons, |
Date of publication, distribution, etc. |
2013. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xvi, 252 p. : |
Other physical details |
ill. ; |
Dimensions |
24 cm. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Essentials of Pharmaceutical Preformulation is a study guide which describes the basic principles of pharmaceutical physicochemical characterisation. Successful preformulation requires knowledge of fundamental molecular concepts (solubility, ionisation, partitioning, hygroscopicity and stability) and macroscopic properties (physical form, such as the crystalline and amorphous states, hydrates, solvates and co-crystals and powder properties), familiarity with the techniques used to measure them and appreciation of their effect on product performance, recognising that often there is a position of compromise to be reached between product stability and bioavailability. This text introduces the basic concepts and discusses their wider implication for pharmaceutical development, with reference to many case examples of current drugs and drug products. Special attention is given to the principles and best-practice of the analytical techniques that underpin preformulation (UV spectrophotometry, TLC, DSC, XRPD and HPLC). The material is presented in the typical order that would be followed when developing a medicine and maps onto the indicative pharmacy syllabus of the Royal Pharmaceutical Society of Great Britain Undergraduate-level pharmacy students and R&D / analytical scientists working in the pharmaceutical sector (with or without a pharmaceutical background) will find this text easy to follow with relevant pharmaceutical examples. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug Compounding |
General subdivision |
methods. |
|
Topical term or geographic name entry element |
Drug Discovery |
General subdivision |
methods. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Saunders, Mark, |
Dates associated with a name |
1959- |
852 ## - LOCATION |
Piece designation |
48143 |
-- |
8193.28 |
Classification part |
615.19 GAI-E |
-- |
Advance Publications |
Sublocation or collection |
Ground Floor |
Former shelving location |
Books |
Copy number |
1 |
Piece physical condition |
1-New |
Location |
JZL-CUI |